| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Thomas Stephen Basil serves as a Director at CLYM. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $6.4M at current prices.
The biggest single holding is CLYM (~$6.4M) as Director. The recent filings there lean toward selling, a net 250,000 shares.